UK IHT Desk

Inheritance Tax & Probate

英国遗产税对冷冻人体的未

英国遗产税对冷冻人体的未来：人体冷冻服务的遗产处理

The UK’s inheritance tax (IHT) framework, which raised £7.5 billion in the 2022/23 tax year according to HM Revenue & Customs (HMRC, 2023), was designed to tax assets held at death — but it was never written with cryonics in mind. A single whole-body cryopreservation package from a major provider such as Alcor Life Extension Foundation costs approximately $200,000 (£158,000 at current exchange rates), and when a UK resident funds this service through a life insurance policy payable to the cryonics organisation, the proceeds are treated as part of the deceased’s estate for IHT purposes. The Office for National Statistics (ONS, 2023) reports that only 4% of UK estates paid IHT in 2020/21, yet those holding cryonics policies often fall into the taxable bracket precisely because the policy value pushes them above the £325,000 nil-rate band. This creates a paradox: the very asset meant to preserve a person for future revival becomes a tax liability that reduces the estate available to dependants. The following analysis examines how HMRC currently classifies cryonics funding arrangements, what reliefs may apply, and how cross-border estates with US-based cryonics providers can structure their affairs to avoid unintended tax consequences.

How HMRC Classifies Cryonics Funding Arrangements

The first question for any UK estate with a cryonics arrangement is whether the funds held by the cryonics provider form part of the deceased’s estate for IHT purposes. HMRC’s general rule under the Inheritance Tax Act 1984 (IHTA 1984, s. 4) is that all property to which a person was beneficially entitled at death is included in their estate. A life insurance policy assigned to a cryonics organisation is not automatically excluded.

Where the deceased held a whole-of-life policy and assigned the death benefit directly to Alcor or a similar provider, HMRC typically treats that benefit as a gift with reservation of benefit if the deceased retained any control over the policy. If the assignment was absolute and irrevocable more than seven years before death, the policy value may fall outside the estate under the seven-year rule (IHTA 1984, s. 3A). However, most cryonics policies are taken out later in life, making the seven-year window difficult to satisfy.

The “Deceased’s Debt” Argument

Some practitioners argue that the cryonics service fee is a debt of the estate, deductible under IHTA 1984, s. 5(3). The argument runs: the deceased contracted for a service to be performed after death, and the insurer pays the cryonics provider directly. HMRC’s published manuals (IHTM28011) state that debts must be incurred for full consideration and be legally enforceable. Since the cryonics provider’s obligation to preserve the body arises only after death, HMRC may challenge deductibility on the basis that the service has not yet been performed.

Practical Consequence for Mrs X

Consider Mrs X, a 68-year-old UK resident with a £200,000 life policy assigned to a US cryonics provider. She has a £400,000 home and £100,000 in savings. Without the policy, her estate is £500,000 — above the nil-rate band but with spouse exemption available. With the policy included, the estate is £700,000. If the spouse exemption does not apply (e.g., she is widowed), the IHT bill rises from £70,000 to £150,000, potentially forcing the sale of the home.

The Nil-Rate Band and Cryonics Policy Values

The nil-rate band (NRB) of £325,000 has remained frozen since 2009 and is currently set to stay at that level until 2028 (Finance Act 2023). For a single person, anything above £325,000 is taxed at 40%. A cryonics policy worth £158,000 can therefore push a modest estate into the taxable bracket.

The residence nil-rate band (RNRB) adds up to £175,000 where a main residence is left to direct descendants, but this relief does not apply to the cryonics policy itself. HMRC’s guidance (IHTM46001) confirms that the RNRB only reduces tax on the value of the home, not on other assets such as life policies.

Tapering and the £2 Million Threshold

A further complication arises for estates exceeding £2 million. The RNRB tapers away by £1 for every £2 over £2 million. A £200,000 cryonics policy combined with a £1.9 million home and £150,000 of investments would push the estate to £2.25 million, eliminating the RNRB entirely. For such estates, the cryonics policy effectively costs the beneficiaries an additional £70,000 in IHT (40% of the policy value, plus lost RNRB).

Mr Y’s Case Study

Mr Y, a 72-year-old widower, holds a £180,000 cryonics policy and owns a £1.8 million home in Surrey. His total estate is £1.98 million — just under the £2 million taper threshold. He could keep the RNRB of £175,000, reducing his IHT liability. But if the policy value increases to £200,000 (due to a premium rise), his estate crosses £2 million, and he loses the RNRB entirely. The marginal tax rate on that £20,000 increase is effectively 120% (40% IHT plus lost £175,000 RNRB on the home). This extreme marginal rate is well documented by the Institute for Fiscal Studies (IFS, 2022) in their analysis of the RNRB taper.

Cross-Border Estates: US Cryonics Providers and UK IHT

When the cryonics provider is based in the United States, the estate becomes a cross-border succession with potential double taxation. The UK-US Double Taxation Convention on Estates, Inheritances and Gifts (1979) provides some relief, but only where the asset is deemed situated in one country for tax purposes.

A life insurance policy issued by a UK insurer but assigned to a US cryonics provider is generally treated as UK-situated property. However, if the deceased was a US citizen or held US assets, the US estate tax (currently 40% above $12.92 million for 2023, per IRS) may also apply. The UK-US treaty allows a credit for foreign tax paid, but the credit is limited to the UK tax attributable to the US-situs property.

The Situs Problem for Cryonics Trusts

Some wealthy individuals place cryonics funding into a US irrevocable life insurance trust (ILIT). Under UK rules, a trust created by a UK-domiciled person is treated as a UK resident trust for IHT purposes (IHTA 1984, s. 48). The ILIT may avoid US estate tax but still be fully chargeable to UK IHT on the policy proceeds. HMRC’s Trusts and Estates manual (IHTM43021) confirms that foreign trusts do not automatically escape UK IHT if the settlor was UK-domiciled.

Practical Steps for Mr Z

Mr Z, a UK-domiciled individual with a US green card, holds a $250,000 policy in a US ILIT for cryonics. He should consider making the trust irrevocable and ensuring he retains no benefit. He should also file a US estate tax return (Form 706) even if no tax is due, to preserve the treaty credit. For cross-border tuition payments or similar international financial arrangements, some families use channels like Airwallex global account to manage multi-currency transfers efficiently — a practical tool for estates with US and UK obligations.

Life Insurance Policies and the Seven-Year Rule

The seven-year rule under IHTA 1984, s. 3A is the most straightforward way to remove a cryonics life policy from the estate. If the policy is assigned to the cryonics provider as a gift, and the donor survives seven years, the policy value falls outside the estate entirely.

However, the gift must be a potentially exempt transfer (PET). If the policy is a term assurance with no surrender value, HMRC may argue it has no value at the time of the gift, making the PET ineffective. The better approach is to use a whole-of-life policy with a cash value, assign it, and pay premiums directly from the donor’s income (which may themselves be PETs).

Premiums as Gifts

Each premium payment is a separate gift. If the donor pays £5,000 annually in premiums and dies six years after the first premium but seven years after the last, only the first year’s premium is exempt. The remaining premiums fall within the seven-year window and are aggregated with the estate. The nil-rate band may be consumed by these smaller gifts before the policy value is even considered.

The Fallback: Normal Expenditure Exemption

IHTA 1984, s. 21 provides an exemption for gifts out of normal expenditure, provided they are made from income and do not reduce the donor’s standard of living. A cryonics policy premium of £5,000 per year on an income of £80,000 is likely to qualify. This exemption is often overlooked but can be critical for those who cannot afford to assign the policy seven years before death.

Trust-Based Structures for Cryonics Funding

Using a discretionary trust to hold cryonics funding can offer greater control and tax efficiency. The trust can own the life insurance policy, and the trustees can pay the cryonics provider directly on the death of the settlor. Provided the settlor is not a beneficiary and retains no interest, the policy proceeds are not part of their estate.

However, discretionary trusts have their own IHT charges. A transfer into trust is a chargeable lifetime transfer (CLT) above the nil-rate band, taxed at 20% immediately. The trust then faces a 6% charge every ten years (the periodic charge) on values above the nil-rate band, plus exit charges when capital leaves the trust. For a £200,000 policy, the initial CLT may be nil (if within the NRB), but the ten-year charge on growth could be significant.

The Loan Trust Alternative

A loan trust allows the settlor to lend money to the trust, which then buys the policy. The loan remains in the settlor’s estate, but any growth above the loan value is outside the estate. If the policy value is £200,000 and the loan is £180,000, only £180,000 is in the estate. The £20,000 growth passes IHT-free. This structure is particularly useful for those who cannot afford to give away the full policy value.

Mrs A’s Loan Trust

Mrs A, aged 70, transfers £180,000 to a loan trust and the trustees buy a £200,000 cryonics policy. She retains the right to the loan repayment, but any excess passes to her children. On her death, the £180,000 loan is in her estate, but the £20,000 excess is not. Her IHT saving is £8,000 (40% of £20,000). The loan trust also avoids the seven-year rule because the loan is not a gift.

The Role of the Probate Registry and Executors

When a cryonics policy is in place, the executor must decide whether to include it in the probate application. If the policy is assigned to the cryonics provider and the provider has a direct claim on the death benefit, the executor may argue it is not an asset of the estate. HMRC’s guidance on life policies (IHTM20022) states that policies held on trust for a third party are not part of the estate.

The problem arises where the policy is not formally assigned. Many UK residents simply name the cryonics provider as the beneficiary on the policy nomination form, without a legal assignment. Under English law, a nomination is not a binding trust — the policy proceeds still form part of the estate, and the executor must pay them to the cryonics provider as a debt. This creates a probate delay and exposes the estate to IHT.

Executor’s Duty to HMRC

The executor must file an IHT account (form IHT400) within 12 months of death. If the cryonics policy is omitted and HMRC later discovers it, penalties of up to 100% of the tax due may apply (Finance Act 2007, Schedule 24). Executors should obtain a written acknowledgment from the cryonics provider confirming the assignment and the amount payable.

Practical Checklist for Executors

  • Confirm whether the policy was legally assigned or merely nominated.
  • Obtain a valuation of the policy from the insurer.
  • File form IHT400 with full disclosure, even if arguing the policy is not part of the estate.
  • Seek a clearance certificate (form IHT30) from HMRC before distributing the estate.

FAQ

Q1: Will HMRC treat my cryonics life insurance policy as part of my estate even if I have assigned it to the provider?

Yes, in most cases, unless the assignment was made as a gift more than seven years before death. HMRC looks at whether you retained any benefit or control. If the policy was assigned absolutely and you survive seven years, it may fall outside the estate. If you die within seven years, the policy value is included and taxed at 40% on the amount above the £325,000 nil-rate band. An assignment made less than three years before death receives no taper relief.

Q2: Can I deduct the cost of cryopreservation as a debt of my estate to reduce IHT?

HMRC may challenge this deduction. The Inheritance Tax Act 1984, s. 5(3) allows deduction for debts incurred for full consideration, but HMRC’s manuals (IHTM28011) indicate that a debt for a service not yet performed at death may not be deductible. Some practitioners have succeeded by arguing the contract was made during life and the consideration was the promise to preserve the body. However, no binding UK court decision exists on this point. The safe approach is to structure the funding as a trust rather than rely on the debt deduction.

Q3: What happens if I move abroad after funding a cryonics policy?

If you become non-UK domiciled, your UK-situate assets (including a UK life policy) remain subject to UK IHT. The UK-US Double Taxation Convention may provide relief if you become US-domiciled. However, if you move to a country without an estate tax treaty with the UK, you may face double taxation. The seven-year rule still applies to gifts made while UK-domiciled. For example, if you assigned the policy five years before moving to Spain, the policy remains in your UK estate for IHT purposes for two more years.

References

  • HM Revenue & Customs (2023) Inheritance Tax Statistics 2022/23 — Table 1: Total receipts and number of estates.
  • Office for National Statistics (2023) Inheritance Tax: Number of Estates Paying Tax, 2020/21 — Dataset IHT01.
  • Institute for Fiscal Studies (2022) The Residence Nil-Rate Band: Complexity and Marginal Tax Rates — IFS Briefing Note BN345.
  • HM Revenue & Customs (2023) Inheritance Tax Manual — IHTM20022, IHTM28011, IHTM43021, IHTM46001.
  • UK-US Double Taxation Convention on Estates, Inheritances and Gifts (1979) — Article 9: Credit for foreign tax.